These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22046568)

  • 1. Multiple myeloma: a review of imaging features and radiological techniques.
    Healy CF; Murray JG; Eustace SJ; Madewell J; O'Gorman PJ; O'Sullivan P
    Bone Marrow Res; 2011; 2011():583439. PubMed ID: 22046568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system.
    Durie BG
    Eur J Cancer; 2006 Jul; 42(11):1539-43. PubMed ID: 16777405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma.
    Narquin S; Ingrand P; Azais I; Delwail V; Vialle R; Boucebci S; Tasu JP
    Diagn Interv Imaging; 2013 Jun; 94(6):629-36. PubMed ID: 23683788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging monoclonal plasma cell disease: comparison of the Durie-Salmon and the Durie-Salmon PLUS staging systems.
    Fechtner K; Hillengass J; Delorme S; Heiss C; Neben K; Goldschmidt H; Kauczor HU; Weber MA
    Radiology; 2010 Oct; 257(1):195-204. PubMed ID: 20851941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloma update.
    Mulligan ME
    Semin Musculoskelet Radiol; 2007 Sep; 11(3):231-9. PubMed ID: 18260033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of whole-body imaging in the diagnosis, staging, and follow-up of multiple myeloma.
    Shortt CP; Carty F; Murray JG
    Semin Musculoskelet Radiol; 2010 Mar; 14(1):37-46. PubMed ID: 20229439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparison of Different Staging Systems for Multiple Myeloma: Can the MRI Pattern Play a Prognostic Role?
    Filonzi G; Mancuso K; Zamagni E; Nanni C; Spinnato P; Cavo M; Fanti S; Salizzoni E; Bazzocchi A
    AJR Am J Roentgenol; 2017 Jul; 209(1):152-158. PubMed ID: 28418695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiological imaging in multiple myeloma: review of the state-of-the-art.
    Di Giuliano F; Picchi E; Muto M; Calcagni A; Ferrazzoli V; Da Ros V; Minosse S; Chiaravalloti A; Garaci F; Floris R; Muto M
    Neuroradiology; 2020 Aug; 62(8):905-923. PubMed ID: 32313979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contribution of whole-body magnetic resonance in the diagnostics of monoclonal gammopathy of undetermined significance, multiple myeloma, and the assessment of Durie-Salmon Plus staging system].
    Scudla V; Herman M; Minarík J; Pika T; Hrbek J; Bacovský J; Heinzová V
    Vnitr Lek; 2011 Jan; 57(1):52-60. PubMed ID: 21351663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-treatment staging of multiple myeloma patients: comparison of whole-body diffusion weighted imaging with whole-body T1-weighted contrast-enhanced imaging.
    Squillaci E; Bolacchi F; Altobelli S; Franceschini L; Bergamini A; Cantonetti M; Simonetti G
    Acta Radiol; 2015 Jun; 56(6):733-8. PubMed ID: 24973257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor load in patients with multiple myeloma: β₂-microglobulin levels versus low-dose whole-body CT.
    Pfahler V; D'Anastasi M; Dürr HR; Schinner R; Ricke J; Baur-Melnyk A
    Eur J Haematol; 2020 May; 104(5):383-389. PubMed ID: 31762076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET/CT.
    Hanrahan CJ; Christensen CR; Crim JR
    Radiographics; 2010 Jan; 30(1):127-42. PubMed ID: 20083590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of multiple myeloma and related plasma cell dyscrasias.
    Walker RC; Brown TL; Jones-Jackson LB; De Blanche L; Bartel T
    J Nucl Med; 2012 Jul; 53(7):1091-101. PubMed ID: 22693310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloma bone and extra-medullary disease: Role of PET/CT and other whole-body imaging techniques.
    Rubini G; Niccoli-Asabella A; Ferrari C; Racanelli V; Maggialetti N; Dammacco F
    Crit Rev Oncol Hematol; 2016 May; 101():169-83. PubMed ID: 26997302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple myeloma.
    Baur-Melnyk A; Reiser MF
    Semin Musculoskelet Radiol; 2009 Jun; 13(2):111-9. PubMed ID: 19455474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma: 18F-FDG-PET/CT and diagnostic imaging.
    Mihailovic J; Goldsmith SJ
    Semin Nucl Med; 2015 Jan; 45(1):16-31. PubMed ID: 25475376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole Body Low Dose Computed Tomography (WBLDCT) Can Be Comparable to Whole-Body Magnetic Resonance Imaging (WBMRI) in the Assessment of Multiple Myeloma.
    Ippolito D; Giandola T; Maino C; Gandola D; Ragusi M; Bonaffini PA; Sironi S
    Diagnostics (Basel); 2021 May; 11(5):. PubMed ID: 34064594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?
    Baur A; Stäbler A; Nagel D; Lamerz R; Bartl R; Hiller E; Wendtner C; Bachner F; Reiser M
    Cancer; 2002 Sep; 95(6):1334-45. PubMed ID: 12216103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Updates in the Role of Imaging for Multiple Myeloma Management Based on Recent International Guidelines.
    Lee K; Kim KW; Ko Y; Park HY; Chae EJ; Lee JH; Ryu JS; Chung HW
    Korean J Radiol; 2021 Sep; 22(9):1497-1513. PubMed ID: 34448381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.